Phase 1 KRAS Mutant Solid Tumors Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

TLN-372 in Advanced KRAS Mutant Solid Tumors

KRAS Mutant Solid Tumors

Treeline Biosciences, Inc.240 enrolled11 locationsNCT07204340

Not Yet Recruiting

Phase 1

A study of TLN-372 in Patients with Advanced KRAS Mutant Solid Tumors.

KRAS Mutant Solid Tumors

Treeline Biosciences, Inc.50 enrolled3 locationsACTRN12626000207314